IP Library Granted Patent US 9,387,169
Granted Patent B2
US 9,387,169 · App. 14/934,491 · Granted Jul 12, 2016

Rapamycin powders for pulmonary delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,387,169
App. No.
14/934,491
Granted
Jul 12, 2016
Kind
B2
Abstract

The invention provides stable, spray-dried, particle formulations containing rapamycin, or pharmaceutically acceptable salts of rapamycin, which are useful for pulmonary administration to the respiratory tract of a patient for the treatment of disease.

Claims (9)

1. A pharmaceutical composition for pulmonary delivery to the respiratory tract of a patient comprising, spray-dried particles of rapamycin and a pharmaceutically acceptable excipient.

2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical excipient comprises one or more of: a phospholipid, a salt, an amino acid or a sugar.

3. The pharmaceutical composition of claim 1 , wherein particles comprise rapamycin in amorphous form.

4. The pharmaceutical composition of claim 1 , wherein the particles comprise rapamycin in crystalline form.

5. The pharmaceutical composition of claim 1 , wherein the particles comprise rapamycin in both crystalline and amorphous forms.

6. A method of delivering rapamycin to the pulmonary system of a patient comprising the steps of:

a) providing a spray-dried particle formulation of claim 1 in a compartment and an inhaler to a patient wherein said powder comprises particles of rapamycin;

b) dispersing the powder by breath actuation of the patient; and

c) delivering the particles to the patient's respiratory system.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 6, 2025
From: CIVITAS THERAPEUTICS, INC.
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 069752/0843 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
SECURITY INTEREST Recorded Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2016
From: LIPP, MICHAEL M.; KAMERKAR, ABHIJIT
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 038189/0511 →